Ablynx NV

Home » Ablynx NV

Secondary

Ablynx NV

They are a late-stage clinical biopharmaceutical company utilizing our proprietary Nanobody platform to develop treatments for a broad range of therapeutic indications with an unmet medical need.

Symbol

ABLX

Last Closing Price
$19.08

Shares
1,000,000

Effective Date
October 25, 2017

Underwriters
BofA Merrill Lynch, J.P. Morgan, Jefferies

To view the prospectus for Ablynx NV, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253